在母乳养期间使用lacosamide:一个案例报告和文献综述
Morgan Cercos1, Ines Seqat2, Anthony Facile1
1Service Hospitalo-Universitaire de Pharmacotoxicologie, Hospices Civils de Lyon, Lyon, France.
Fundamental & clinical pharmacology
|December 6, 2023
概括
拉科萨米德是一种抗发作药物,当作为单疗法使用时,似乎对母乳养婴儿是安全的. 虽然它会进入母乳,但在报告的病例中,婴儿的血液水平和不良反应是最小的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 新生儿医学 新生儿医学
- 神经学 神经学
背景情况:
- 拉科萨米德是一种用于治疗的抗发作药物 (ASM).
- 哺乳对母亲和婴儿都有显著的益处.
- 有限的数据存在于lacosamide转移到母乳和婴儿安全.
研究的目的:
- 评估lacosamide在母乳养婴儿中的安全性和有效性.
- 为了评估乳母乳和婴儿血清中的lacosamide度.
- 审查现有的关于乳房期间使用lacosamide的文献.
主要方法:
- 一个母亲接受了治疗的lacosamide的病例报告,她母乳养了她的婴儿.
- 关于八个先前报告的乳房哺乳母亲使用lacosamide的病例的文献评论.
- 分析婴儿血液中的lacosamide度和报告的药物不良反应 (ADRs).
主要成果:
- 婴儿的lacosamide血度处于参考范围内.
- 大多数母乳养婴儿没有报告任何不良药物反应.
- 相对婴儿剂量 (RID) 不同,有些病例尽管RID较高,但度较低.
结论:
- 哺乳可能是可能的健康的,满期的婴儿,其母亲在lacosamide单疗法.
- 建议对嗜睡,体重增加和皮疹进行临床监测.
- 长期的神经发育结果仍然未知,如果发生ADR,可能需要血清水平.
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...


